Search

Author/Creator Dacci, P.

1. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database. (9th August 2019)

Authors:
Doneddu, P. E.; Bianchi, E.; Cocito, D.; Manganelli, F.; Fazio, R.; Filosto, M.; Mazzeo, A.; Cosentino, G.; Cortese, A.; Jann, S.; Clerici, A. M.; Antonini, G.; Siciliano, G.; Luigetti, M.; Marfia, G. A.; Briani, C.; Lauria, G.; Rosso, T.; Cavaletti, G.; Carpo, M.
Journal:
European journal of neurology
Issue:
Volume 27:Number 1(2020)
Page Start:
136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Subcutaneous immunoglobulin (SCIG) for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: The PATH Study. Issue 1 (January 2019)

Authors:
Cocito, D.; Peci, E.; Lauria Pinter, G.; Dacci, P.; Di Muzio, A.; Telese, R.; Schenone, A.; Benedetti, L.; Antonini, G.; Morino, S.; Sorbi, S.; Matà, S.; Bril, V.; van Geloven, N.; Hartung, H.-P.; Lewis, R.A.; Sobue, G.; Lawo, J.-P.; Mielke, O.; Durn, B.L.
Journal:
Clinical neurophysiology
Issue:
Volume 130:Issue 1(2019:Jan.)
Page Start:
e10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Feasibility of switching from intravenous to subcutaneous immunoglobulin in CIDP: PATH trial and clinical experience. Issue 1 (January 2019)

Authors:
Cocito, D.; Peci, E.; Lauria Pinter, G.; Dacci, P.; Di Muzio, A.; Telese, R.; Schenone, A.; Benedetti, L.; Antonini, G.; Morino, S.; Sorbi, S.; Matà, S.; Bril, V.; van Geloven, N.; Hartung, H-P.; Lewis, R.A.; Sobue, G.; Lawo, J.-P.; Mielke, O.; Durn, B.L.
Journal:
Clinical neurophysiology
Issue:
Volume 130:Issue 1(2019:Jan.)
Page Start:
e12
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search